A high level of soluble B2M is detected in several types of cancers, including breast [4], colorectal [5], gastric [6], lung [7], oral [8], ovarian [9], prostate [10] and testicular [11] cancers, and may be implicated in the immune escape of cancer cells and cancer immunotherapy [12–15]. The gene discussed is B2M; the disease is cancer.